| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |